$43.29
2.24%
NYSE, Jan 02, 10:10 pm CET
Why the stock moved Why the stock moved Beta
ISIN
US26622P1075
Symbol
DOCS

Doximity Stock News

Neutral
PRNewsWire
●
12 days ago
Shareholders should contact the firm immediately as there may be limited time to enforce your rights. Β  NEW YORK , Dec. 24, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Doximity Inc. (NYSE: DOCS) breached their fiduciary duties to shareholders.
Positive
MarketBeat
●
18 days ago
At the start of the new year, investors seeking a fresh approach might consider stocks that are positioned for a reset. Companies trading at or near their lowest level for 2025 could be primed for gains in the new year if conditions are right.
Positive
Seeking Alpha
●
29 days ago
Doximity's Q2 results show record engagement and accelerating adoption of AI workflow tools, signaling deeper physician reliance on the platform. Revenue quality is improving as pharma clients shift from one-off ad buys to longer-term integrated programs. Doximity has a strong Rule-of-50 profile with high margins and $890m cash but no debt.
Neutral
24/7 Wall Street
●
about one month ago
CVNA last traded at $313.25 a share after finding support at $285.02,Β which was double-bottom support dating back to June 2025.
Neutral
Seeking Alpha
●
about 2 months ago
Doximity, Inc. ( DOCS ) Q2 2026 Earnings Call November 6, 2025 5:00 PM EST Company Participants Perry Gold - Head of Investor Relations Jeffrey Tangney - Co-Founder, CEO & Chairperson Anna Bryson - Chief Financial Officer Conference Call Participants Brian Peterson - Raymond James & Associates, Inc., Research Division Michael Cherny - Leerink Partners LLC, Research Division Allen Lutz - BofA Se...
Neutral
Business Wire
●
about 2 months ago
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2026 second quarter ended September 30, 2025. β€œOur platform continues to grow with new AI tools to save physicians' time,” said Jeff Tangney, co-founder and CEO of Doximity. β€œIn Q2, a record 650,000 prescribers used our workflow tools to...
Neutral
Business Wire
●
2 months ago
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Doximity Inc. (NYSE: DOCS) breached their fiduciary duties to shareholders. If you currently own Doximity stock and acquired shares on or before June 24, 2021, you may be able to seek corporate governance reforms, the return of funds back to the company, a court-a...
Neutral
Business Wire
●
3 months ago
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal second quarter ended September 30, 2025 after market close on November 6, 2025. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results. To listen to a liv...

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today